NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/21/2025
Back to search
Official data from USPTO
UNIBODY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
UNIBODY
ST13
US500000079034253Class
1, 5, 42
Filing
79034253
Registration
3312952
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
53
Latest update
03/21/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
10/19/2006
Registration date
10/16/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/03/2018
Last transaction
06/05/2024
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
84
Owner location
DK
Examiner
GUTTADAURO, JULIE MARIE
Law office
L60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Genmab A/S
Representatives
Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biochemicalsnamely monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancerAIDS (acquired immune deficiency syndrome)other infectious diseasesimmune and autoimmune diseasesinflammatory diseases and cardiovascular diseases
Class 5
Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancerAIDS (acquired immune deficiency syndrome) and other infections diseasesimmune and autoimmune diseasesinflammatory diseases and cardiovascular diseases
Class 42
Medical and scientific researchnamely biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancerAIDS (acquired immune deficiency syndrome) and other infectious diseasesimmune and autoimmune diseasesinflammatory diseases and cardiovascular diseases; chemical analysis; patent exploitationpatent licensing; licensing of intellectual property in the field of medicine; computer programmingnamely programming of computers for the collection and processing of medical data in medical scientific researchdevelopment and therapy with monoclonal antibodies
Publications
History of USPTO decisions and trademark events.
53 publications found
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/05/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/05/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/05/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/05/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/05/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/15/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/03/2018
71AG
REGISTERED-SEC.71 ACCEPTED
05/03/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/03/2018
ES71
TEAS SECTION 71 RECEIVED
04/16/2018
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/26/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/08/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/20/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/09/2017
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/09/2017
RNWL
INTERNATIONAL REGISTRATION RENEWED
11/03/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED
05/12/2014
71AG
REGISTERED-SEC.71 ACCEPTED
05/12/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/12/2014
71AF
REGISTERED-SEC.71 FILED
04/16/2014
ES71
TEAS SECTION 71 RECEIVED
04/16/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/11/2011
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/15/2010
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/15/2009
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
05/08/2008
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
05/08/2008
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/28/2008
FIMP
FINAL DISPOSITION PROCESSED
01/28/2008
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/22/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
10/16/2007
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
09/27/2007
PUBO
PUBLISHED FOR OPPOSITION
07/31/2007
NPUB
NOTICE OF PUBLICATION
07/11/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/26/2007
ALIE
ASSIGNED TO LIE
06/25/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/24/2007
ACEC
AMENDMENT FROM APPLICANT ENTERED
05/31/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/31/2007
ALIE
ASSIGNED TO LIE
05/31/2007
PAPER RECEIVED
05/14/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/09/2007
FAXX
FAX RECEIVED
05/09/2007
RFNP
REFUSAL PROCESSED BY IB
03/29/2007
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/13/2007
RFRR
REFUSAL PROCESSED BY MPU
03/13/2007
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/11/2007
CNRT
NON-FINAL ACTION WRITTEN
03/10/2007
DOCK
ASSIGNED TO EXAMINER
03/04/2007
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
03/02/2007
NWAP
NEW APPLICATION ENTERED
03/01/2007
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/01/2007
Continuous trademark protection
Get notified about every new filing that threatens UNIBODY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.